ZA200903283B - Phenylalkylamino carbamate compositions - Google Patents
Phenylalkylamino carbamate compositionsInfo
- Publication number
- ZA200903283B ZA200903283B ZA200903283A ZA200903283A ZA200903283B ZA 200903283 B ZA200903283 B ZA 200903283B ZA 200903283 A ZA200903283 A ZA 200903283A ZA 200903283 A ZA200903283 A ZA 200903283A ZA 200903283 B ZA200903283 B ZA 200903283B
- Authority
- ZA
- South Africa
- Prior art keywords
- carbamate compositions
- phenylalkylamino carbamate
- phenylalkylamino
- compositions
- carbamate
- Prior art date
Links
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82934206P | 2006-10-13 | 2006-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200903283B true ZA200903283B (en) | 2010-07-28 |
Family
ID=39111348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200903283A ZA200903283B (en) | 2006-10-13 | 2009-05-12 | Phenylalkylamino carbamate compositions |
Country Status (19)
Country | Link |
---|---|
US (1) | US20080090902A1 (es) |
EP (1) | EP2079449A2 (es) |
JP (1) | JP2010506845A (es) |
KR (1) | KR20090082213A (es) |
CN (1) | CN101557804A (es) |
AU (1) | AU2007313017A1 (es) |
BR (1) | BRPI0719275A2 (es) |
CA (1) | CA2673487A1 (es) |
CO (1) | CO6180500A2 (es) |
CR (1) | CR10794A (es) |
EA (1) | EA200970377A1 (es) |
GT (1) | GT200900082A (es) |
IL (1) | IL198145A0 (es) |
MX (1) | MX2009003926A (es) |
NI (1) | NI200900053A (es) |
NO (1) | NO20091530L (es) |
SV (1) | SV2009003221A (es) |
WO (1) | WO2008048801A2 (es) |
ZA (1) | ZA200903283B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1890684T3 (pl) | 2005-06-08 | 2014-05-30 | Sk Biopharmaceuticals Co Ltd | Leczenie zaburzeń snu i czuwania |
US8741950B2 (en) | 2009-06-22 | 2014-06-03 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
CN102781436B (zh) | 2009-11-06 | 2014-01-08 | 爱思开生物制药株式会社 | 纤维肌痛综合征的治疗方法 |
RU2556585C2 (ru) | 2009-11-06 | 2015-07-10 | Ск Биофармасъютиклс Ко., Лтд. | Способы лечения синдрома дефицита внимания и гиперактивности |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
EP2968210A4 (en) | 2013-03-12 | 2016-12-28 | Bio-Pharm Solutions Co Ltd | PHENYL ACARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILEPSY AND EPILEPSY-MEDIATED SYNDROME |
US9907776B2 (en) | 2013-03-12 | 2018-03-06 | Bio-Pharm Solutions, Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same |
TWI684450B (zh) | 2013-03-13 | 2020-02-11 | 南韓商愛思開生物製藥股份有限公司 | 猝倒症之治療 |
EP3021838B1 (en) | 2013-07-18 | 2020-05-27 | Jazz Pharmaceuticals Ireland Limited | Treatment for obesity |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
WO2018222954A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals International Iii Limited | Methods and compositions for treating excessive sleepiness |
CN110037995B (zh) * | 2019-04-17 | 2021-07-06 | 石家庄龙泽制药股份有限公司 | 一种稳定的盐酸帕罗西汀片剂及其制备方法 |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
IT202000013855A1 (it) | 2020-06-10 | 2021-12-10 | Flamma Spa | Un processo per la purificazione del (r)-2-ammino-3-fenilpropil carbammato |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3342687A (en) * | 1964-06-25 | 1967-09-19 | Colgate Palmolive Co | Oral preparation |
US3420817A (en) * | 1966-12-06 | 1969-01-07 | Hoffmann La Roche | 4,1,5-benzoxadiazocin-2-ons and processes for preparing same |
US6043211A (en) * | 1988-02-02 | 2000-03-28 | The Regents Of The University Of California | Method for inhibiting the activity of a platelet-derived growth factor receptor binding protein |
KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
US5756817C1 (en) * | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
KR0173862B1 (ko) * | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
KR0173863B1 (ko) * | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
WO1998015526A1 (en) * | 1996-10-10 | 1998-04-16 | Sk Corporation | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
US20020151543A1 (en) * | 1998-05-28 | 2002-10-17 | Sepracor Inc. | Compositions and methods employing R (-) fluoxetine and other active ingredients |
WO2002017921A2 (en) * | 2000-08-28 | 2002-03-07 | Synthon B.V. | Paroxetine compositions and processes for making the same |
-
2007
- 2007-10-08 KR KR1020097009750A patent/KR20090082213A/ko not_active Application Discontinuation
- 2007-10-08 US US11/868,555 patent/US20080090902A1/en not_active Abandoned
- 2007-10-08 CN CNA2007800458003A patent/CN101557804A/zh active Pending
- 2007-10-08 EA EA200970377A patent/EA200970377A1/ru unknown
- 2007-10-08 MX MX2009003926A patent/MX2009003926A/es not_active Application Discontinuation
- 2007-10-08 BR BRPI0719275-4A2A patent/BRPI0719275A2/pt not_active IP Right Cessation
- 2007-10-08 EP EP07843957A patent/EP2079449A2/en not_active Withdrawn
- 2007-10-08 AU AU2007313017A patent/AU2007313017A1/en not_active Abandoned
- 2007-10-08 WO PCT/US2007/080675 patent/WO2008048801A2/en active Application Filing
- 2007-10-08 JP JP2009532514A patent/JP2010506845A/ja active Pending
- 2007-10-08 CA CA002673487A patent/CA2673487A1/en not_active Abandoned
-
2009
- 2009-04-13 NI NI200900053A patent/NI200900053A/es unknown
- 2009-04-13 GT GT200900082A patent/GT200900082A/es unknown
- 2009-04-14 SV SV2009003221A patent/SV2009003221A/es unknown
- 2009-04-14 CO CO09037414A patent/CO6180500A2/es not_active Application Discontinuation
- 2009-04-16 IL IL198145A patent/IL198145A0/en unknown
- 2009-04-17 NO NO20091530A patent/NO20091530L/no not_active Application Discontinuation
- 2009-05-12 ZA ZA200903283A patent/ZA200903283B/xx unknown
- 2009-05-13 CR CR10794A patent/CR10794A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20080090902A1 (en) | 2008-04-17 |
JP2010506845A (ja) | 2010-03-04 |
AU2007313017A1 (en) | 2008-04-24 |
CN101557804A (zh) | 2009-10-14 |
NO20091530L (no) | 2009-07-06 |
MX2009003926A (es) | 2009-06-26 |
BRPI0719275A2 (pt) | 2014-04-29 |
WO2008048801A2 (en) | 2008-04-24 |
CO6180500A2 (es) | 2010-07-19 |
GT200900082A (es) | 2010-02-24 |
EA200970377A1 (ru) | 2009-10-30 |
NI200900053A (es) | 2010-02-01 |
WO2008048801A3 (en) | 2008-06-05 |
KR20090082213A (ko) | 2009-07-29 |
CR10794A (es) | 2009-09-29 |
IL198145A0 (en) | 2009-12-24 |
EP2079449A2 (en) | 2009-07-22 |
CA2673487A1 (en) | 2008-04-24 |
SV2009003221A (es) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200903283B (en) | Phenylalkylamino carbamate compositions | |
AP2008004547A0 (en) | Petsticidal compositions | |
EP2040708A4 (en) | CROSS-CONTAINING COMPOSITIONS | |
GB0503337D0 (en) | Compositions | |
IL186721A0 (en) | Bioenhanced compositions | |
GB0624290D0 (en) | Novel compositions | |
GB0526283D0 (en) | Compositions | |
GB0607085D0 (en) | Novel compositions | |
GB0625069D0 (en) | Compositions | |
IL186093A0 (en) | Lignan-containing compositions | |
GB0501365D0 (en) | Compositions | |
GB0620279D0 (en) | Compositions | |
GB0524128D0 (en) | Compositions | |
GB0618657D0 (en) | Compositions | |
IL199056A0 (en) | Acetaminophen compositions having minimized side effects including reduced hepato-toxicity | |
EP1986849A4 (en) | COMBUSTION REMOVAL COMPOSITIONS, RESISTANT TO WASH | |
ZA200903284B (en) | Phenylalkyl carbamate compositions | |
ZA200709913B (en) | Bioenhanced compositions | |
GB0522045D0 (en) | Pharmaceutical compositions | |
GB0620918D0 (en) | Compositions | |
GB0526282D0 (en) | Compositions | |
EP1845944A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
GB0917779D0 (en) | Novel compositions | |
GB0601899D0 (en) | Compositions | |
GB0611033D0 (en) | Compositions |